Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm receives postive feedback from FDA type c meeting

Dec 18, 2020 at 3:01 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment